AHA News: Determined to Ignore the Warning Signs, He’s Put That Same Determination Into Heart Attack Recovery
2021-07-27
Determined to Ignore the Warning Signs, He’s Put That Same Determination Into Heart Attack RecoveryContinue Reading
Severe COVID for People Under 45: Who’s Most at Risk?
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — Young people aren’t immune from severe COVID-19, and a new study warns that some are more at risk than others. Folks under 45 have more than triple the risk for severe COVID-19 if they have cancer or heart disease, or blood, neurologic orContinue Reading
Could Heavy Marijuana Use Be Driving Rise in Schizophrenia Cases?
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — There’s been a sharp rise in schizophrenia cases linked with marijuana use since the mid-1990s, a new Danish study finds. Prior research has suggested that marijuana — particularly very heavy use — is associated with an increased risk of schizophrenia. Although strict cause-and-effectContinue Reading
Delta Variant Spreads More Easily, Causing CDC Change on Indoor Masking
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — Unlike prior strains, the Delta variant is triggering higher viral loads in rare cases of “breakthrough” infections in people fully vaccinated against COVID-19, making transmission more likely and causing the U.S. Centers for Disease Control and Prevention to call for everyone to wearContinue Reading
Despite Reopening, Britain Sees 6 Straight Days of Declines in COVID Cases
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — COVID-19 cases in Britain have fallen for six days in a row, even though the government lifted all but a few social distancing restrictions last week. The shift has scientists scratching their heads, as many of them predicted a powerful surge in casesContinue Reading
Health Highlights: July 27, 2021
2021-07-27
Here’s some of HealthDay’s top stories for Tuesday, July 27: Choosing the best blood pressure drug for you. A study involving data on more than 3 million people focused on two major classes of drugs used to lower high blood pressure — ACE inhibitors and angiotensin receptor blockers (ARBs). DependingContinue Reading
Federal, State Moves Begin to Mandate COVID Vaccines for Workers
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — In a sign that the United States has reached a “tipping point” in its campaign to vaccinate Americans, California and New York City announced vaccine or testing mandates for their employees on Monday while the Department of Veterans Affairs said its frontline healthContinue Reading
Long COVID May Qualify as a Disability: Biden
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — Serious “long COVID” symptoms could qualify as a disability and make patients eligible for federal assistance, President Joe Biden said Monday. Some recovered COVID-19 patients have lasting problems such as fatigue, brain fog, joint pain, fever and double vision, which “can sometimes riseContinue Reading
Pfizer, Moderna to Expand Vaccine Studies in Young Children
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11, to more closely measure the risk of heart inflammation and other rare side effects that occurred in teens and young adults who received the vaccines. The companiesContinue Reading
High Blood Pressure: Which Drug Works Best for You?
2021-07-27
TUESDAY, July 27, 2021 (HealthDay News) — Two long used types of blood pressure drugs are equally effective, but the less popular one seems to have fewer side effects, according to a large “real-world” study. The two classes of medication are both recommended as “first-line” treatments for high blood pressure:Continue Reading